Application of wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis

HIGHLIGHTS

  • who: Mahshid Saleh from the Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement Sponsor: Universidad de la Sabana have published the article: Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis, in the Journal: (JOURNAL) of August/23,/2021
  • what: This study examined the paradox of the TGF-u03b21 pro-fibrotic factor in stimulating u03b1-SMA expression and myofibroblast differentiation and showed that excessive TGF-u03b21 secretion from MSC cells increased IP-10 levels in UIP-HLF (Usual interstitial pneumoniahuman primary lung . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?